Key BIOS facts and Figures – 2022

Open

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Open

Removing access barriers in Central and Eastern Europe – April 2022

Open

Factsheet: The EU Bolar Exemption

Read more

Note on Transferable Vouchers – April 2022

Open

Biosimilar Medicines Reading List

Position Paper – Unitary SPC & Unified Mechanism for the Granting of SPCs

Open

Policy recommendations on uptake of biosimilar medicines in the retail market


Policy recommendations on uptake of biosimilar medicines in the retail market (November 2021)


Unlocking the potential of the biosimilar retail market (November 2021)


Retail policy algorithm: Policy recommendations to unlock the potential of the biosimilar retail market Retail policy algorithm – Paper version (November 2021)


Retail policy algorithm: Policy recommendations to unlock the potential of the biosimilar retail market Retail policy algorithm – Interactive version (November 2021)

Positioning Statements on Physician-led Switching for Biosimilar Medicines


Positioning statements on physician-led switching for biosimilar medicines (October 2021)


Biosimilar medicines group position on physician-led switching (July 2015)


Biosimilar medicines group position on biologic pharmacy substitution (September 2020)

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

Open